HMOX1 and neoplasm: Evidence that the severity of TTR-HO is highly dependent on the complexity of tumor treatment34,35, as well as evidence that morbidity and mortality are correlated with factors such as female sex, childhood onset, and tumor recurrence underline the importance of individualized monitoring of symptoms and comorbidities36.